BioSpace News Archive

Peptides, short sections of proteins made up of chains of amino acids, are an important area of new drug development due to their potential for increased specificity and fewer side effects.

InnovaQor, Inc. (OTC: VMCS), Chief Executive Officer Sharon Hollis recently joined Stock Day host Everett Jolly to provide a summary of the business activities of InnovaQor.

The growth of the personalized medicine biomarkers market is attributed to increasing demand and growing awareness about personalized medicine among healthcare professionals.

The global heparin market size was USD 6.76 Billion in 2020 and is expected to register a CAGR of 1.4% during the forecast period.

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will deliver presentations on its epilepsy programs at the American Epilepsy Society (AES) 2022 Annual Meeting.

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Rachael Easton, MD, Ph.D., Vice President, Head of Clinical Development.

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical Trial (“Trial”) status. COSIRA-II is the U.S. Investigational Device Exemption (“IDE”) pivotal clinical trial the Company is executing for the Neovasc Reducer™ (“Reducer”) towards an approval decision for the device in the United States.

mRNA is synthesized in the nucleus with the use of a template made up of a DNA nucleotide sequence.

The global bronchoscopy market size is expected to reach USD 3,174.0 Million in 2030 and register a revenue CAGR of 5.5% during the forecast period.

Quest Diagnostics (NYSE: DGX), the nation’s leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of select assets of LabCare Plus, the outreach laboratory services business of Summa Health, a large integrated health system.